Free Trial

Small Cap Stocks To Follow Today - October 6th

Spruce Biosciences logo with Medical background

Key Points

  • Seven small-cap stocks are highlighted for October 6th, including Spruce Biosciences, Critical Metals, and Society Pass, known for their high trading volumes recently.
  • Spruce Biosciences is focused on biopharmaceuticals, particularly developing a therapy for congenital adrenal hyperplasia, currently in Phase 2b clinical trials.
  • Richtech Robotics specializes in automation solutions for the service industry, offering products such as delivery and sanitation robots.
  • Interested in Spruce Biosciences? Here are five stocks we like better.

Spruce Biosciences, Critical Metals, Inflection Point Acquisition Corp. II, Society Pass, OneMedNet, Spring Valley Acquisition, and Richtech Robotics are the seven Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—typically between about $300 million and $2 billion. Because these firms are less established, their shares can offer higher growth potential but also tend to be more volatile and risky than large-cap stocks. Investors often include small caps in their portfolios to diversify and capitalize on the growth of emerging businesses. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Spruce Biosciences (SPRB)

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial.

Read Our Latest Research Report on SPRB

Critical Metals (CRML)

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Read Our Latest Research Report on CRML

Inflection Point Acquisition Corp. II (IPXX)

Read Our Latest Research Report on IPXX

Society Pass (SOPA)

Society Pass Incorporated acquires and operates fintech and e-commerce platforms and mobile applications for consumers and merchants in Singapore, Vietnam, Indonesia, Philippines, the United States, Malaysia, Hong Kong, and Thailand. It operates through Online Grocery and Food and Groceries Deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-Commerce, and Merchant Point of Sale segments.

Read Our Latest Research Report on SOPA

OneMedNet (ONMD)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.

Read Our Latest Research Report on ONMD

Spring Valley Acquisition (SV)

Read Our Latest Research Report on SV

Richtech Robotics (RR)

Richtech Robotics Inc. develops, manufactures, deploys, and sells robotic solutions for automation in the service industry. The company offers indoor transport and delivery, sanitation, and food and beverage automation solutions, such as ADAM and ARM worker robots; delivery robots, including Matradee, Matradee X, Matradee L, Richie, and Robbie; and cleaning robots comprising DUST-E SX, and DUST-E MX, as well as accessories, such as bus tubs, cup holders, magnetic tray cases, smartwatches, table location systems, and tray covers.

Read Our Latest Research Report on RR

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Spruce Biosciences Right Now?

Before you consider Spruce Biosciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spruce Biosciences wasn't on the list.

While Spruce Biosciences currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.